Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 03/26 07:11:49 am
78.285 EUR   +0.42%
03/25Lexicon Pharma Shares Down Almost 10% on FDA Rejection
DJ
03/25GLOBAL MARKETS LIVE : Apple, Apax, Boeing, Daimler…
03/22FDA Rejects Oral Treatment for Type 1 Diabetes - Update
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sanofi : $621.13 Million Federal Contract Awarded to Sanofi Pasteur

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 03:42am EDT

ATLANTA, Georgia, Jan. 11 -- Sanofi Pasteur Inc., Swiftwater, Pennsylvania, won a $621,134,986 federal contract from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention for pediatric influenza vaccines.

Agency contacts: Monica D. Shaw, 770/488-8213, monica.shaw@cdc.hhs.gov; or Pellumbeshe Hoxhaj, 770/488-2805, kfx2@cdc.gov. CIV5FCA5. CLASS65; NAICS325412.

For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897.

© 2019 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
04:58aSANOFI : and Lexicon`s Zynquista denied type 1 diabetes approval by FDA complete..
AQ
03/25Lexicon Pharma Shares Down Almost 10% on FDA Rejection
DJ
03/25GLOBAL MARKETS LIVE : Apple, Apax, Boeing, Daimler…
03/23LEXICON PHARMACEUTICALS : to Host Conference Call and Webcast Today, March 22, 2..
AQ
03/22FDA Rejects Oral Treatment for Type 1 Diabetes - Update
DJ
03/22FDA Rejects Oral Treatment for Type 1 Diabetes
DJ
03/22SANOFI : FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)
AQ
03/22SANOFI : Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 C..
AQ
03/22UNIVERSITY OF DUNDEE : Exscientia announces new AI pharma collaboration
AQ
03/22ROCHE : Celgene and Evotec's partner Exscientia enter 3-year AI drug discovery c..
AQ
More news
Financials (€)
Sales 2019 36 172 M
EBIT 2019 9 222 M
Net income 2019 5 147 M
Debt 2019 14 002 M
Yield 2019 4,08%
P/E ratio 2019 17,87
P/E ratio 2020 15,97
EV / Sales 2019 3,08x
EV / Sales 2020 2,86x
Capitalization 97 296 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 83,4 €
Spread / Average Target 7,0%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI3.04%110 044
JOHNSON & JOHNSON5.86%363 761
NOVARTIS10.09%237 528
ROCHE HOLDING LTD.10.42%232 888
PFIZER-4.03%232 565
MERCK AND COMPANY7.77%212 563